Cxlusa: Clinical Trials

7 trials sponsored by Cxlusa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated, 2 completed. 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Not applicable1Completed 1

Follow Cxlusa: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas
CXLO Corneal Strengthening Solution and UVA Illumination Device - Keratoconus, Corneal Diseases
Phase 2TerminatedCxlusa22282016-12-212022-01-12
CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Theralight crosslinking and Riboflavin - Keratoconus
Phase 2TerminatedCxlusa13242013-01-012018-10-12
Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of Ectasia
Corneal Cross-Linking, Riboflavin - Fruste Keratoconus, Risk of Ectasia
CompletedCxlusa222011-10-012015-08-24
Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
Ultraviolet-A and riboflavin - Infectious Keratitis
Not applicableCompletedCxlusa132011-08-012018-09-26
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Ciprofloxicin or Vigamox or other., Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc), Steroid (FML, Pred Forte, Flarex, etc.) - Keratoconus, Ectasia
TerminatedCxlusa34932010-02-012018-10-12
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Keratoconus, Ectasia
TerminatedCxlusa26192009-12-012018-10-11
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Ciprofloxicine or Vigamox or other., Nonsteroidal (Acular, Voltaren Xibrom, etc), Steroid (FML, Pred Forte, Flarex, etc.) - Keratoconus, Ectasia
TerminatedCxlusa11892009-10-012018-10-11

Conditions studied

Keratoconus (5)  ·  Dilatation, Pathologic (4)  ·  Corneal Diseases (1)  ·  Eye Diseases (1)

Interventions

Riboflavin (3)  ·  Fluorometholone (2)  ·  Ketorolac Tromethamine (2)  ·  Moxifloxacin (2)  ·  Steroids (2)  ·  prednisolone acetate (2)  ·  Corneal Cross-Linking (1)  ·  Ketorolac (1)

Countries

United States (7)

Top investigators

William Trattler, MD (5)  ·  Parag Majmudar, MD (2)  ·  Audrey Rostov, MD (1)  ·  Bradley Bowman, M.D (1)  ·  Daniel Goodman, MD (1)  ·  Gregg Berdy, MD (1)  ·  Gregg J Berdy, MD, FACS (1)  ·  Jay Schwartz, MD (1)  ·  Jodi Luchs, MD (1)  ·  John Hovanesian, MD (1)  ·  Jonathan Davidorf, MD (1)  ·  Jonathan Talamo, MD (1)  ·  Lance Forstot (1)  ·  Lance Forstot, MD (1)  ·  Mark Kontos, MD (1)

Results publications

PMID 36173242